New challenges for sleep apnea research ...[Editorial]: simple diagnostic tools, biomarkers, new treatments and precision medicine (2017)
- Autor:
- Autor USP: DRAGER, LUCIANO FERREIRA - FM
- Unidade: FM
- DOI: 10.5935/1984-0063.20170009
- Subjects: BIOMARCADORES; APNEIA DO SONO; TERAPÊUTICA MÉDICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Sleep science
- ISSN: 1984-0659
- Volume/Número/Paginação/Ano: v. 10, n. 1, p. 55-56, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DRAGER, Luciano Ferreira. New challenges for sleep apnea research ..[Editorial]: simple diagnostic tools, biomarkers, new treatments and precision medicine. Sleep science. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.5935/1984-0063.20170009. Acesso em: 24 jan. 2026. , 2017 -
APA
Drager, L. F. (2017). New challenges for sleep apnea research ..[Editorial]: simple diagnostic tools, biomarkers, new treatments and precision medicine. Sleep science. São Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.5935/1984-0063.20170009 -
NLM
Drager LF. New challenges for sleep apnea research ..[Editorial]: simple diagnostic tools, biomarkers, new treatments and precision medicine [Internet]. Sleep science. 2017 ; 10( 1): 55-56.[citado 2026 jan. 24 ] Available from: https://doi.org/10.5935/1984-0063.20170009 -
Vancouver
Drager LF. New challenges for sleep apnea research ..[Editorial]: simple diagnostic tools, biomarkers, new treatments and precision medicine [Internet]. Sleep science. 2017 ; 10( 1): 55-56.[citado 2026 jan. 24 ] Available from: https://doi.org/10.5935/1984-0063.20170009 - Resistant hypertension: time to consider the best fifth anti-hypertensive treatment
- Rationale and methodology of the SARAH Trial: Long-term cardiovascular outcomes in patients with resistant hypertension and obstructive sleep apnea
- Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial
- Bariatric Surgery for Resistant Hypertension: Working in Progress!
- OSA and cardiometabolic risk: What's the bottom line?
- Are we missing obstructive sleep apnea diagnosis?[Editorial]
- Apneia Obstrutiva do Sono e Aterosclerose: uma abordagem translacional
- Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals
- OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study
- Obstructive Sleep Apnea and Diabetes Independently Add to Cardiovascular Risk After Coronary Revascularization [Carta]
Informações sobre o DOI: 10.5935/1984-0063.20170009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
